Community acquisition of ESBL-producing Escherichia coli: a growing concern

Justin T Denholm, Michael Huysmans and Denis Spelman
Med J Aust 2009; 190 (1): . || doi: 10.5694/j.1326-5377.2009.tb02266.x
Published online: 5 January 2009

To the Editor: Extended-spectrum-β-lactamases (ESBLs) are enzymes capable of hydrolysing penicillins, broad-spectrum cephalosporins and monobactams. Worldwide, ESBL-producing organisms are posing an increasing challenge for empirical antibiotic use and infection control.

  • Justin T Denholm
  • Michael Huysmans
  • Denis Spelman

  • Alfred Hospital, Melbourne, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.